Beta blockers and angiotensin-converting enzyme inhibitors’ purported benefit on breast cancer survival may be explained by aspirin use

Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

(2015)   Oncotarget

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

(2012) Annemijn M Algra et al.   LANCET ONCOLOGY

Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort

(2011) Patricia A. Ganz et al.   BREAST CANCER RESEARCH AND TREATMENT

COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin

(2011) Michelle D. Holmes et al.   BREAST CANCER RESEARCH AND TREATMENT

Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins

(2011) Young Kwang Chae et al.   CANCER INVESTIGATION

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

(2011) Thomas I. Barron et al.   JOURNAL OF CLINICAL ONCOLOGY

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

(2011) Amal Melhem-Bertrandt et al.   JOURNAL OF CLINICAL ONCOLOGY

Common cardiovascular medications in cancer therapeutics

(2011) Christos Vaklavas et al.   PHARMACOLOGY & THERAPEUTICS

The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer

(2010) E. K. Sloan et al.   CANCER RESEARCH

Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway

(2010) Yanbin Zhao et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Aspirin Intake and Survival After Breast Cancer

(2010) Michelle D. Holmes et al.   JOURNAL OF CLINICAL ONCOLOGY

Potential role of Renin–Angiotensin-system for tumor angiogenesis in receptor negative breast cancer

(2008) D. Herr et al.   GYNECOLOGIC ONCOLOGY